About Gambro
Gambro is a company based in Lund (Sweden) founded in 1964 was acquired by Baxter in September 2013. Gambro has completed 2 acquisitions, including CHF Solutions and Cobe Chemical. Gambro operates in a competitive market with competitors including Outset Medical, Fresenius, Hemotune, NxStage and Diality, among others.
- Headquarter Lund, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Baxter
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
CHF Solutions
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Gambro
Unlock access to complete
Unlock access to complete
Software Development Team
288 people
Leadership Team
121 people
Sales and Marketing
70 people
Senior Team
38 people
Operations Team
30 people
Product Management Team
27 people
Human Resources and Administration
25 people
Finance and Accounting
20 people
Unlock access to complete
Funding Insights of Gambro
Detailed funding history for Gambro
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Gambro
Gambro has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Baxter, EQT and Investor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Investments are directed by the Wallenberg family into Nordic sectors.
|
Locked | Locked | Locked | |
|
Biosciences, medication delivery, and renal products are developed and marketed.
|
Locked | Locked | Locked |
Investor details for Gambro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gambro
Gambro has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CHF Solutions and Cobe Chemical.
Investment portfolio details for Gambro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Ultrafiltration devices are provided for treating fluid overload in patients.
|
Locked | Locked | 1999 | Locked | |
|
Liquids, creams, and lotions are manufactured under contract.
|
Locked | Locked | 1970 | Locked |
Complete acquisition details for Gambro
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Gambro
Detailed financials for Gambro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gambro Comparisons
Peer comparison for Gambro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gambro
Gambro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Outset Medical, Fresenius, Hemotune, NxStage and Diality, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hemodialysis machines with touchscreen displays are provided for medical use.
|
|
| Locked | Locked | Locked |
System-critical products and services for healthcare therapies are provided.
|
|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Home and critical care dialysis systems
|
|
| Locked | Locked | Locked |
Developer of portable hemodialysis device
|
|
| Locked | Locked | Locked |
Blood purification equipment for kidney failure patients is provided.
|
Detailed competitors of Gambro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gambro
Complete news archive for Gambro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gambro
Gambro was founded in 1964.
Gambro is headquartered in Lund, Sweden.
Thomas Glanzmann is the current CEO of Gambro.
Gambro was founded in 1964 in Lund, Sweden, as a medical technology company. Products and therapies for kidney and liver dialysis, myeloma kidney therapy, and extracorporeal treatments are developed, manufactured, and supplied for both chronic and acute patients. The offerings include hemodialysis monitors, dialyzers, bloodlines, vascular access needles, and acute care hemofilters, along with data management tools. Operations focus on global distribution within the healthcare sector.
Gambro's top competitors include Outset Medical, Fresenius and Diality.
Gambro has made 2 acquisitions, including CHF Solutions, and Cobe Chemical.